Methohexital Recall: Avet Pharmaceuticals injection vial
Announced 2026-07-15 · FDA
The FDA is recalling 4,284 vials of Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, distributed nationwide in the United States. The recall is due to failed impurities/degradation specifications. The vials were manufactured by OneSource Specialty Pharma Limited for Avet Pharmaceuticals Inc. and have Lot 7000612A with Exp. 01/2028.
| Brand | ONESOURCE SPECIALTY PHARMA LIMITED |
|---|---|
| Product | Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31 |
| Reason | Failed Impurities/Degradation Specifications |
| Severity | moderate |
| Units affected | 4284 |
| Distribution | Nationwide within the United States |
| Agency | FDA |
| Recall / campaign no. | Lot #: 7000612A, Exp. Date 1/2028 |
WHAT YOU SHOULD DO
- Do not use or administer any recalled Methohexital Sodium for Injection vials.
- Locate and segregate any affected vials using Lot 7000612A and Exp. 01/2028.
- Contact Avet Pharmaceuticals or OneSource Specialty Pharma Limited for return or disposal instructions.
- If you have used the product and have concerns, consult your healthcare provider.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.